Amarantus Therapeutics Secures $1,299,327 New Round

  • Feed Type
  • Date
    9/3/2013
  • Company Name
    Amarantus Therapeutics
  • Mailing Address
    675 Almanor Avenue Sunnyvale, CA 94085
  • Company Description
    The company is developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases.
  • Website
    http://www.amarantustherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,299,327
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.